These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 10777219

  • 1. Lack of germline CDK6 mutations in familial melanoma.
    Shennan MG, Badin AC, Walsh S, Summers A, From L, McKenzie M, Goldstein AM, Tucker MA, Hogg D, Lassam N.
    Oncogene; 2000 Mar 30; 19(14):1849-52. PubMed ID: 10777219
    [Abstract] [Full Text] [Related]

  • 2. Individuals with presumably hereditary uveal melanoma do not harbour germline mutations in the coding regions of either the P16INK4A, P14ARF or cdk4 genes.
    Soufir N, Bressac-de Paillerets B, Desjardins L, Lévy C, Bombled J, Gorin I, Schlienger P, Stoppa-Lyonnet D.
    Br J Cancer; 2000 Feb 30; 82(4):818-22. PubMed ID: 10732752
    [Abstract] [Full Text] [Related]

  • 3. CDKN2A and CDK4 mutation analysis in Italian melanoma-prone families: functional characterization of a novel CDKN2A germ line mutation.
    Della Torre G, Pasini B, Frigerio S, Donghi R, Rovini D, Delia D, Peters G, Huot TJ, Bianchi-Scarra G, Lantieri F, Rodolfo M, Parmiani G, Pierotti MA.
    Br J Cancer; 2001 Sep 14; 85(6):836-44. PubMed ID: 11556834
    [Abstract] [Full Text] [Related]

  • 4. The p16-cyclin D/Cdk4-pRb pathway as a functional unit frequently altered in melanoma pathogenesis.
    Bartkova J, Lukas J, Guldberg P, Alsner J, Kirkin AF, Zeuthen J, Bartek J.
    Cancer Res; 1996 Dec 01; 56(23):5475-83. PubMed ID: 8968104
    [Abstract] [Full Text] [Related]

  • 5. CDKN2A germ-line mutations in individuals with multiple cutaneous melanomas.
    Hashemi J, Platz A, Ueno T, Stierner U, Ringborg U, Hansson J.
    Cancer Res; 2000 Dec 15; 60(24):6864-7. PubMed ID: 11156381
    [Abstract] [Full Text] [Related]

  • 6. Mutations associated with familial melanoma impair p16INK4 function.
    Ranade K, Hussussian CJ, Sikorski RS, Varmus HE, Goldstein AM, Tucker MA, Serrano M, Hannon GJ, Beach D, Dracopoli NC.
    Nat Genet; 1995 May 15; 10(1):114-6. PubMed ID: 7647780
    [Abstract] [Full Text] [Related]

  • 7. Functional, structural, and genetic evaluation of 20 CDKN2A germ line mutations identified in melanoma-prone families or patients.
    Kannengiesser C, Brookes S, del Arroyo AG, Pham D, Bombled J, Barrois M, Mauffret O, Avril MF, Chompret A, Lenoir GM, Sarasin A, French Hereditary Melanoma Study Group, Peters G, Bressac-de Paillerets B.
    Hum Mutat; 2009 Apr 15; 30(4):564-74. PubMed ID: 19260062
    [Abstract] [Full Text] [Related]

  • 8. Novel mutations in the p16/CDKN2A binding region of the cyclin-dependent kinase-4 gene.
    Tsao H, Benoit E, Sober AJ, Thiele C, Haluska FG.
    Cancer Res; 1998 Jan 01; 58(1):109-13. PubMed ID: 9426066
    [Abstract] [Full Text] [Related]

  • 9. Characterization of the cyclin-dependent kinase inhibitory domain of the INK4 family as a model for a synthetic tumour suppressor molecule.
    Fåhraeus R, Laín S, Ball KL, Lane DP.
    Oncogene; 1998 Feb 05; 16(5):587-96. PubMed ID: 9482104
    [Abstract] [Full Text] [Related]

  • 10. Lack of germ-line mutations of CDK4, p16(INK4A), and p15(INK4B) in families with glioma.
    Gao L, Liu L, van Meyel D, Cairncross G, Forsyth P, Kimmel D, Jenkins RB, Lassam NJ, Hogg D.
    Clin Cancer Res; 1997 Jun 05; 3(6):977-81. PubMed ID: 9815774
    [Abstract] [Full Text] [Related]

  • 11. Disruption of the cyclin D/cyclin-dependent kinase/INK4/retinoblastoma protein regulatory pathway in human neuroblastoma.
    Easton J, Wei T, Lahti JM, Kidd VJ.
    Cancer Res; 1998 Jun 15; 58(12):2624-32. PubMed ID: 9635589
    [Abstract] [Full Text] [Related]

  • 12. Interaction of retinoblastoma protein and D cyclins during cell-growth inhibition by hexamethylenebisacetamide in TM2H mouse epithelial cells.
    Said TK, Medina D.
    Mol Carcinog; 1998 Jun 15; 22(2):128-43. PubMed ID: 9655257
    [Abstract] [Full Text] [Related]

  • 13. A CDKN2A mutation in familial melanoma that abrogates binding of p16INK4a to CDK4 but not CDK6.
    Jones R, Ruas M, Gregory F, Moulin S, Delia D, Manoukian S, Rowe J, Brookes S, Peters G.
    Cancer Res; 2007 Oct 01; 67(19):9134-41. PubMed ID: 17909018
    [Abstract] [Full Text] [Related]

  • 14. Predicting functional significance of cancer-associated p16(INK4a) mutations in CDKN2A.
    McKenzie HA, Fung C, Becker TM, Irvine M, Mann GJ, Kefford RF, Rizos H.
    Hum Mutat; 2010 Jun 01; 31(6):692-701. PubMed ID: 20340136
    [Abstract] [Full Text] [Related]

  • 15. Screening of germline mutations in the CDK4, CDKN2C and TP53 genes in familial melanoma: a clinic-based population study.
    Platz A, Hansson J, Ringborg U.
    Int J Cancer; 1998 Sep 25; 78(1):13-5. PubMed ID: 9724087
    [Abstract] [Full Text] [Related]

  • 16. CDKN2A (P16(INK4a)) and CDK4 mutation analysis in 131 Australian melanoma probands: effect of family history and multiple primary melanomas.
    Holland EA, Schmid H, Kefford RF, Mann GJ.
    Genes Chromosomes Cancer; 1999 Aug 25; 25(4):339-48. PubMed ID: 10398427
    [Abstract] [Full Text] [Related]

  • 17. Germline mutations in the p16INK4a binding domain of CDK4 in familial melanoma.
    Zuo L, Weger J, Yang Q, Goldstein AM, Tucker MA, Walker GJ, Hayward N, Dracopoli NC.
    Nat Genet; 1996 Jan 25; 12(1):97-9. PubMed ID: 8528263
    [No Abstract] [Full Text] [Related]

  • 18. Germline p16INK4A mutation and protein dysfunction in a family with inherited melanoma.
    Liu L, Lassam NJ, Slingerland JM, Bailey D, Cole D, Jenkins R, Hogg D.
    Oncogene; 1995 Jul 20; 11(2):405-12. PubMed ID: 7624155
    [Abstract] [Full Text] [Related]

  • 19. p16 proteins from melanoma-prone families are deficient in binding to Cdk4.
    Reymond A, Brent R.
    Oncogene; 1995 Sep 21; 11(6):1173-8. PubMed ID: 7566978
    [Abstract] [Full Text] [Related]

  • 20. Mutation testing in melanoma families: INK4A, CDK4 and INK4D.
    Newton Bishop JA, Harland M, Bennett DC, Bataille V, Goldstein AM, Tucker MA, Ponder BA, Cuzick J, Selby P, Bishop DT.
    Br J Cancer; 1999 Apr 21; 80(1-2):295-300. PubMed ID: 10390011
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.